Evidence map›Paper›PMID 40163054›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2025

Improving Community-Engaged Implementation Science: Perspectives From "Ending the HIV Epidemic" Supplement Award Cases in the United States.

Laura K Beres, Audrey Harkness, Jessica Corcoran, Reva Datar, Amy Corneli, Jonathan Ross, Maria Pyra, Katherine Rucinski, Gabriela Betancourt, Phillip Marotta and 6 more

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Laura K BeresJohns Hopkins Bloomberg School of Public Health, Baltimore, MD.ORCID 0000-0002-4731-7828
Audrey HarknessUniversity of Miami, Miami, FL.
Jessica CorcoranUniversity of Alabama at Birmingham School of Nursing, Birmingham, AL.
Reva DatarJohns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Amy CorneliDepartment of Population Health Sciences, Duke University School of Medicine, Durham, NC.
Jonathan RossAlbert Einstein College of Medicine, Bronx, NY.
Maria PyraInstitute for Sexual and Gender Minority Health and Well Being, Northwestern University, Chicago, IL.
Katherine RucinskiJohns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Gabriela BetancourtLatino Commission on AIDS, New York, NY.
Phillip MarottaWashington University in St. Louis, St. Louis, MO.
Pedro SerranoInstitute for Sexual and Gender Minority Health and Well Being, Northwestern University, Chicago, IL.
Christopher G KempJohns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Christopher J HoffmannJohns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Stefan BaralJohns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Sheree SchwartzJohns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Debbie HumphriesYale School of Public Health, New Haven, CT.

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul A. Goepfert · 1988 to 2026
$84.1M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Anna Palmer Durbin · 2012 to 2026
$67.0M
Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
Using Coincidence Analysis to Investigate Factors Affecting PrEP Initiation and Continuation in Southern ending the Epidemic CountiesP30MH062294 · NIMH · YALE UNIVERSITY · PI Trace S Kershaw · 2001 to 2026
$48.5M
Virology and Immunology Technology CoreP30AI117943 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Sahera Dirajlal-Fargo · 2015 to 2026
$38.4M
Patient and Population Health Outcomes Research SWGP30AI124414 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Vinayaka R. Prasad · 2017 to 2026
$28.3M
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)Research Core & MHD-CEP30MH133399 · NIMH · UNIVERSITY OF MIAMI CORAL GABLES · PI Victoria Behar-Zusman · 2023 to 2026
$8.9M
University of Miami Developmental HIV/AIDS Mental Health Research Center (D-ARC)P30MH116867 · NIMH · UNIVERSITY OF MIAMI CORAL GABLES · PI SAFREN, STEVEN A · 2019 to 2023
$6.5M
Johns Hopkins HIV Epidemiology and Prevention Sciences Training ProgramT32AI102623 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Shruti H Mehta · 2013 to 2026
$5.3M
Integrating the Visualization and Use of Stigma Data to Maximize the Impact of the Ending the HIV Epidemic InitiativeR01MH132150 · NIMH · JOHNS HOPKINS UNIVERSITY · PI Stefan David Baral · 2022 to 2026
$5.1M
The Johns Hopkins and Emory University AIDS Research Center – Center for HIV and Mental Health Stigma Elimination Strategies (CHIMES) P30MH136919 · NIMH · JOHNS HOPKINS UNIVERSITY · PI Tiara C. Willie · 2024 to 2026
$2.9M
Developing and Pilot Testing Peer Ambassador Stories for Increasing HIV-Prevention and Behavioral Health Treatment Uptake among Latino MSMK23MD015690 · NIMHD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI HARKNESS, AUDREY · 2020 to 2025
$1.1M
NIAID NIH HHS P30 AI027767NIAID NIH HHS P30 AI064518NIAID NIH HHS P30 AI094189NIAID NIH HHS P30 AI117943NIAID NIH HHS P30 AI124414NIAID NIH HHS T32 AI102623NIMHD NIH HHS K23 MD015690NIMH NIH HHS K01 MH129226NIMH NIH HHS K01 MH130244NIMH NIH HHS P30 MH062294NIMH NIH HHS P30 MH116867NIMH NIH HHS P30 MH133399NIMH NIH HHS P30 MH136919NIMH NIH HHS R01 MH132150
6 · The paper itself

Abstract

backgroundCommunity-engaged research (CEnR) is fundamental to effective HIV prevention and treatment implementation, although limited in practice. We describe CEnR lessons learned by researchers in HIV-related implementation science to improve future CEnR.

settingAcademic-community research partnerships funded by the 2019-2021 National Institutes of Health Ending the HIV Epidemic (EHE) supplement awards.

methodsSeven individual awardees representing 8 EHE awards documented partnership characteristics and key CEnR experiences in an online form. Three semi-structured reflection sessions subsequently discussed experiences, identifying opportunities and barriers using qualitative thematic analysis, iterative dialogue, and illustrative case studies.

resultsAwardees identified both partnerships newly established for the grant (60%) and preexisting collaborations (40%). Key perceived CEnR benefits included: new and better project ideas; improved project implementation; and priorities to guide future research. Prominent barriers included: administrative burdens resulting in delayed funding access that constrained partner engagement; limited grant timelines and funding for essential preimplementation partnership building; and limited recognition of key CEnR activities in academic success metrics. Adaptive responses to barriers included focusing short award periods on exploratory aims and building on extant community activities.

conclusionsSystems-level redesign at the funder and university levels could improve CEnR equity, including accepting financial risk between grant award and funding receipt to facilitate completion of essential prework such as Institutional Review Board approvals and prevent the exclusion of the more financially constrained community partners or forcing unfunded effort provision and establishing appropriate support and promotion criteria for CEnR-engaged faculty. Thus, enabling CEnR good practices can improve future HIV-related implementation research and EHE goal achievement.

Indexed as

Community-Based Participatory ResearchEpidemicsHIV InfectionsImplementation ScienceAwards and PrizesHumansNational Institutes of Health (U.S.)United States

Identifiers

PMID40163054
PMCPMC12187905

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.